The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing
Open accessAbstract
Inherited loss-of-function mutations in the tumor suppressor genes BRCA1 , BRCA2 , and multiple other genes predispose to high risks of breast and/or ovarian cancer. Cancer-associated inherited mutations in these genes are collectively quite common, but individually rare or even private. Genetic testing for BRCA1 and BRCA2 mutations has become an integral part of clinical practice, but testing is generally limited to these two genes and to women with severe family histories of breast or ovarian cancer. To determine whether massively parallel, “next-generation” sequencing would enable accurate, thorough, and cost-effective identification of inherited mutations for breast and ovarian cancer, we developed a genomic assay to capture, sequence, and detect all mutations in 21 genes, including BRCA1 and BRCA2 , with inherited mutations that predispose to breast or ovarian cancer. Constitutional genomic DNA from subjects with known inherited mutations, ranging in size from 1 to >100,000 bp, was hybridized to custom oligonucleotides and then sequenced using a genome analyzer. Analysis was carried out blind to the mutation in each sample. Average coverage was >1200 reads per base pair. After filtering sequences for quality and number of reads, all single-nucleotide substitutions, small insertion and deletion mutations, and large genomic duplications and deletions were detected. There were zero false-positive calls of nonsense mutations, frameshift mutations, or genomic rearrangements for any gene in any of the test samples. This approach enables widespread genetic testing and personalized risk assessment for breast and ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Mapping short DNA sequencing reads and calling variants using mapping quality scores
Li, H., Ruan, J., & Durbin, R. (2008) · Genome Research · doi:10.1101/gr.078212.108 · Cited by 2,638
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Self-citationPetitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1×
“, p53_721G > A) (18), we also compared all variants to gene-specific mutation databases.”
ResultCancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Target-enrichment strategies for next-generation sequencing
Mamanova, L., Coffey, A. J., Scott, C. E., Kozarewa, I., Turner, E. H., Kumar, A., Howard, E., Shendure, J., & Turner, D. J. (2010) · Nature Methods · doi:10.1038/nmeth.1419 · Cited by 1,219
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
Li, C., & Hung Wong, W. (2001) · Genome Biology · doi:10.1186/gb-2001-2-8-research0032 · Cited by 976
Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome
Hearle, N., Schumacher, V., Menko, F. H., Olschwang, S., Boardman, L. A., Gille, J. J. P., Keller, J. J., Westerman, A. M., Scott, R. J., Lim, W., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0083 · Cited by 855
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J., Lee, M. K., Ciernikova, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 666
Self-citationBeyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Gonzalez, K. D., Noltner, K. A., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 609
Berry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.121 · Cited by 505
Ten Genes for Inherited Breast Cancer
Walsh, T., & King, M.-C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.010 · Cited by 477
Self-citationFrank, T. S., Manley, S. A., Olopade, O. I., Cummings, S., Garber, J. E., Bernhardt, B., Antman, K., Russo, D., Wood, M. E., Mullineau, L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2417 · Cited by 455
Hogervorst, F. B. L., Nederlof, P. M., Gille, J. J. P., McElgunn, C. J., Grippeling, M., Pruntel, R., Regnerus, R., van Welsem, T., van Spaendonk, R., Menko, F. H., et al. (2003) · PubMed · Cited by 314
A standardized framework for the validation and verification of clinical molecular genetic tests
for the EuroGentest Validation Group, Mattocks, C. J., Morris, M. A., Matthijs, G., Swinnen, E., Corveleyn, A., Dequeker, E., Müller, C. R., Pratt, V., & Wallace, A. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.101 · Cited by 205 · cited 1×
“Guidelines for application of next-generation sequencing to genetic diagnostics are currently under development (30).”
BackgroundHereditary diffuse gastric cancer: association with lobular breast cancer
Schrader, K. A., Masciari, S., Boyd, N., Wiyrick, S. J., Kaurah, P., Senz, J., Burke, W., Lynch, H. T., Garber, J. E., & Huntsman, D. D. (2007) · Familial Cancer · doi:10.1007/s10689-007-9172-6 · Cited by 132
Enrichment of sequencing targets from the human genome by solution hybridization
Tewhey, R., Nakano, M., Wang, X., Pabón-Peña, C., Novak, B. A., Giuffre, A. C., Lin, E., Happe, S., Roberts, D. N., LeProust, E. M., et al. (2009) · Genome biology · doi:10.1186/gb-2009-10-10-r116 · Cited by 124
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
Euhus, D., Smith, K. C., Robinson, L., Stucky, A., Olopade, O., Cummings, S., Garber, J., Chittenden, A., Mills, G., Rieger, P., et al. (2002) · Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.844 · Cited by 114
Massively parallel sequencing of ataxia genes after array-based enrichment
Hoischen, A., Gilissen, C., Arts, P., Wieskamp, N., van der Vliet, W., Vermeer, S., Steehouwer, M., de Vries, P., Meijer, R. P. P., Sequeiros, J., et al. (2010) · Human Mutation · doi:10.1002/humu.21221 · Cited by 112
Genetic diagnosis of familial breast cancer using clonal sequencing
Morgan, J., Carr, I., Sheridan, E. G., Chu, C. E., Hayward, B. E., Camm, N., Lindsay, H. A., Mattocks, C., Markham, A. F., Bonthron, D. T., et al. (2010) · Human Mutation · doi:10.1002/humu.21216 · Cited by 85
Goossens, D., Moens, L., Nelis, E., Lenaerts, A., Glassee, W., Kalbe, A., Frey, B., Kopal, G., Jonghe, P. D., Rijk, P. D., et al. (2008) · Human Mutation · doi:10.1002/humu.20873 · Cited by 71
Chou, L., Liu, C.-S. J., Boese, B., Zhang, X., & Mao, R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.132639 · Cited by 67
Microarray-based multicycle-enrichment of genomic subsets for targeted next-generation sequencingPreprint
Summerer, D., Wu, H., Haase, B., Cheng, Y., Schracke, N., Stähler, C., Chee, M. S., Stähler, P. F., & Beier, M. (2009) · Genome Research · doi:10.1101/gr.091942.109 · Cited by 52
Individual Genomes on the Horizon
Lifton, R. P. (2010) · New England Journal of Medicine · doi:10.1056/nejme1001090 · Cited by 46
Targeted High-Throughput DNA Sequencing for Gene Discovery in Retinitis Pigmentosa
Daiger, S. P., Sullivan, L. S., Bowne, S. J., Birch, D. G., Heckenlively, J. R., Pierce, E. A., & Weinstock, G. M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_37 · Cited by 45
Gene Patenting — Is the Pendulum Swinging Back?
Kesselheim, A. S., & Mello, M. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1004026 · Cited by 23
Schroeder, C., Stutzmann, F., Weber, B. H. F., Rieß, O., & von Bonin, M. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0639-z · Cited by 21
Cited by
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Pritchard, C. C., Mateo, J., Walsh, M. F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603144 · Cited by 1,680
Self-citationEpithelial ovarian cancer: Evolution of management in the era of precision medicine
Lheureux, S., Braunstein, M., & Oza, A. M. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21559 · Cited by 1,423
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D., Böhm, S., Ahmed, A. A., Aspuria, P.-J., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S., Bookman, M. A., et al. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4019 · Cited by 1,367
Metadata
- Authors
- Walsh, T., Lee, M. K., Casadei, S., Thornton, A. M., Stray, S. M., Pennil, C., Nord, A. S., Mandell, J. B., Swisher, E. M., & King, M.-C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-06-28
- Volume
- 107
- Issue
- 28
- Pages
- 12629-12633
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2106542343
- Cited by
- 487
- References
- 30
- FWCI
- 21.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.